first_imgJust a year ago, Ghanaian policeman Samuel Sarfo was photographed guarding the country’s national footballers before an international game.Incredibly, 12 months on, Sarfo has himself made his debut for the Black Stars, coming on as a substitute in Ghana’s 2-1 defeat to USA in Connecticut on Saturday.The 26-year-old is also captain of top flight Ghanaian side Liberty Professionals and combines his footballing life with his duties as a police officer.He told Focus on Africa’s sports presenter Nishat Ladha that the secret behind his recent success was that he grew up with the players he had been assigned to guard.They gave him advice on how best to manage himself as a policeman and a player.Samuel Sarfo added that “it was a dream come true. That is the dream of every young chap growing up in Ghana. To don the national colours, I happen to be one of them”last_img read more

first_img Country * Afghanistan Aland Islands Albania Algeria Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia, Plurinational State of Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, the Democratic Republic of the Cook Islands Costa Rica Cote d’Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See (Vatican City State) Honduras Hungary Iceland India Indonesia Iran, Islamic Republic of Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Korea, Democratic People’s Republic of Korea, Republic of Kuwait Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, the former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Martinique Mauritania Mauritius Mayotte Mexico Moldova, Republic of Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Norway Oman Pakistan Palestine Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Qatar Reunion Romania Russian Federation Rwanda Saint Barthélemy Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Martin (French part) Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten (Dutch part) Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania, United Republic of Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Venezuela, Bolivarian Republic of Vietnam Virgin Islands, British Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe Sign up for our daily newsletter Get more great content like this delivered right to you! Country Click to view the privacy policy. Required fields are indicated by an asterisk (*) Emailcenter_img On Friday, the National Institutes of Health (NIH) revealed that it had begun to phase out controversial monkey experiments at one of its labs in Poolesville, Maryland. The action followed an aggressive yearlong campaign by People for the Ethical Treatment of Animals (PETA), but an NIH director tells ScienceInsider today that financial straits—not animal rights pressures—led to the decision.“NIH has to make decisions on how to spend its research dollars regardless of what others may think,” says Constantine Stratakis, the scientific director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which oversees the lab in question. “Clearly the timing is awkward, but I can assure you that PETA was not a factor in this decision.”The lab is run by Stephen Suomi, who has been at NICHD since 1983. His team studies how early environment shapes behavior—work that involves separating young rhesus macaques from their mothers, measuring their addiction to alcohol, and monitoring their long-term stress levels. PETA has been targeting the lab since last year. It ran extensive ad campaigns, successfully pushed for a congressional inquiry, and—most recently—sent hundreds of letters to the neighbors of Suomi and NIH Director Francis Collins, accusing the lab of “cruel psychological experiments” and revealing both Suomi’s and Collins’s home addresses and telephone numbers.“They did the right thing by shutting down this work,” says Justin Goodman, PETA’s director of laboratory investigations. “It’s a historic moment that appears to be the death knell for horrendous maternal deprivation experiments.”But Stratakis says the decision was purely financial. For decades, the animal facility in Poolesville was shared by many of the agency’s institutes, including NICHD, the National Cancer Institute, and the National Institute of Mental Health. A number of these institutes have decided to pull out because they couldn’t afford to stay there, he says, leaving NICHD to assume the costs of running the entire facility. “For us, it wasn’t tenable in the long run.”Stratakis says that NICHD decided this summer to begin phasing out the animal work at Suomi’s lab, the only NICHD lab at Poolesville. It currently houses about 300 monkeys, all of which will be transferred to other facilities over the course of the next 3 years. In the meantime, Suomi’s team can continue working with the animals it has, but it cannot breed new ones. “It won’t be business as usual,” Stratakis says.Still, some are concerned that NICHD’s action will be seen as a victory for the animal rights movement. “If these types of strategies are influencing decisions about scientific research, that would be very worrying,” says Tom Holder, the director of Speaking of Research, an international organization that supports the use of animals in scientific labs. “NIH needs to stand up for the value of animal studies and allow its researchers to speak more clearly to the public about their work.”Stratakis says the Poolesville monkeys may still be used in research after they leave Suomi’s lab. And he says the work itself has been invaluable. “There is a treasure trove of material that has been collected over the years,” he says. “The lab has made critical observations on the impact of certain behavior on genetics.” Even after the animals leave, he says, researchers will be able to analyze any remaining serum, DNA, and tissue samples. “This work is going to produce amazing data.” (Suomi did not respond to a request for comment.)In the end, Goodman says PETA is just happy the macaques are leaving the lab. “We don’t care why NIH made its decision. We just care about the monkeys.” He says his group will continue to put pressure on the agency to end all federally funded experiments of nonhuman primates. “We’re also trying to get NIH to start counting the number of mice and rats it uses.”last_img read more